Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Ophthalmol Ther ; 11(2): 479-487, 2022 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-35092605

RESUMEN

The treatment of non-infectious uveitis affecting the posterior segment of the eye has been revolutionized by the development of sustained-release corticosteroid implants over the past decade. Their use is now supported by healthcare systems that have licensed and commissioned them on the basis of the high-quality randomised controlled trials that formed part of their development and which have informed clinicians as to their benefits and risks. In particular, they have provided an alternative mode of treatment for patients who do not wish to be systemically immunosuppressed, or in whom such immunosuppression is less desirable, such as those with unilateral disease or those with concurrent illnesses such as diabetes mellitus, renal disease or osteoporosis that are negatively impacted by systemic corticosteroids or other immunosuppressive agents. In this article, we review the evidence for the use of the major licensed corticosteroid implants and assess the advantages and disadvantages of each.

2.
Sci Rep ; 11(1): 21432, 2021 11 02.
Artículo en Inglés | MEDLINE | ID: mdl-34728652

RESUMEN

To compare the safety and efficacy of phacoemulsification combined with ab-interno trabeculectomy (Trabectome) and phacoemulsification combined with I-Stent inject in patients with medically uncontrolled primary open-angle glaucoma (POAG). A retrospective comparative case series. 70 eyes of 66 patients completed 2 years follow up after these treatments performed in 2017-2018. 35 eyes of 33 patients underwent combined Phaco-Trabectome (PT); and 35 eyes of 33 patients underwent combined Phaco-I-Stent inject (Pi). Patient demographics and preoperative characteristics are comparable. A 20% drop in IOP was achieved in 27 eyes (77.14%) in PT group and 28 eyes (80%) in Pi group (p = 0.77). Success rate (target IOP achieved and maintained for 2 years) in advance glaucoma was 25% in PT group and 30.7% in Pi group (p = 0.90). In mild to moderate glaucoma, success rate was 85.71% in PT group and 90% in Pi group (p = 0.67). There was no significant difference between two groups with regards to mean reduction in glaucoma medications and complication rates. Trabectome and I-Stent combined with phacoemulsification are equally efficacious and safe for treating patients with medically uncontrolled mild and moderate primary open-angle glaucoma (POAG). However, they are not an effective treatment for patients with advanced glaucoma.


Asunto(s)
Glaucoma de Ángulo Abierto/cirugía , Procedimientos Quirúrgicos Mínimamente Invasivos/métodos , Stents , Malla Trabecular/cirugía , Trabeculectomía/métodos , Anciano , Femenino , Glaucoma de Ángulo Abierto/patología , Humanos , Presión Intraocular , Masculino , Estudios Retrospectivos , Malla Trabecular/patología , Resultado del Tratamiento
3.
Pan Afr Med J ; 40: 95, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34909083

RESUMEN

Sino-orbital aspergillosis is an uncommon but aggressive infection. It rarely originates from the frontal sinus due to the complex anatomy of the frontal recess and anteromedial position of its ostium. An 87-year-old man of Nigerian heritage with a history of multiple myeloma, chronic kidney disease and type 2 diabetes, presented to the eye clinic with a right tense swollen eyelid and proptosis. Computed tomography (CT) and magnetic resonance imaging (MRI) scan revealed a right superomedial mass communicating with the frontal sinus and biopsy confirmed an orbital aspergilloma. The patient was successfully treated with debulking surgery and anti-fungal treatment despite developing side effects to the drugs. To improve prognosis, ophthalmologists should be aware of this distinct entity and use a multi-disciplinary approach.


Asunto(s)
Aspergilosis , Diabetes Mellitus Tipo 2 , Seno Frontal , Sinusitis Frontal , Enfermedades Orbitales , Anciano de 80 o más Años , Antifúngicos/uso terapéutico , Aspergilosis/diagnóstico , Aspergilosis/tratamiento farmacológico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Seno Frontal/diagnóstico por imagen , Humanos , Enfermedades Orbitales/diagnóstico , Enfermedades Orbitales/etiología
4.
Ocul Immunol Inflamm ; 28(6): 898-907, 2020 Aug 17.
Artículo en Inglés | MEDLINE | ID: mdl-31418609

RESUMEN

PURPOSE: New instrument-based techniques for anterior chamber (AC) cell counting can offer automation and objectivity above clinician assessment. This review aims to identify such instruments and its correlation with clinician estimates. METHODS: Using standard systematic review methodology, we identified and tabulated the outcomes of studies reporting reliability and correlation between instrument-based measurements and clinician AC cell grading. RESULTS: From 3470 studies, 6 reported correlation between an instrument-based AC cell count to clinician grading. The two instruments were optical coherence tomography (OCT) and laser flare-cell photometry (LFCP). Correlation between clinician grading and LFCP was 0.66-0.87 and 0.06-0.97 between clinician grading and OCT. OCT volume scans demonstrated correlation between 0.75 and 0.78. Line scans in the middle AC demonstrated higher correlation (0.73-0.97) than in the inferior AC (0.06-0.56). CONCLUSION: AC cell count by OCT and LFP can achieve high levels of correlation with clinician grading, whilst offering additional advantages of speed, automation, and objectivity.


Asunto(s)
Cámara Anterior/patología , Fotometría/instrumentación , Tomografía de Coherencia Óptica/instrumentación , Uveítis/diagnóstico , Recuento de Células , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA